Medigus (MDGS.TA) Announces Three-Year Follow Up Study Presented At Digestive Disease Week 2014 Showing Treatment With MUSE™ System Keeps Patients Off Daily PPI Therapy
5/7/2014 9:19:04 AM
OMER, Israel, May 7, 2014 (GLOBE NEWSWIRE) -- Medigus Ltd. (TASE: MDGS), a medical device company developing minimally-invasive, endosurgical tools and procedures, announced today that two presentations involving the use of its MUSE(TM) System (formerly the SRS(TM) System) were presented at the prominent Digestive Disease® Week (DDW) annual meeting, the largest international gathering of physicians, researchers and academics in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery, which took place this week in Chicago IL.
Help employers find you! Check out all the jobs and post your resume.
comments powered by